Subgroup analysis showed that high ENO1 expression was associated with worse prognosis, regardless of age, gender, lymph node metastasis, degree of differentiation, neural invasion, and TNM stage (P<0.05, Figure 2). Here, ENO1 is linked to metastatic malignant neoplasm in the lymph nodes.